Expression of TCP1 was upregulated in 93% of HCC patients and 76% of colon cancer patients, while CCT2 was overexpressed in 100% of HCC patients and 82% of colon cancer patients (24). This evidence concerns the gene CCT2 and malignant colon neoplasm.